Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
批准号:
10007353
负责人:
Olga V Fedorova
金额:
$131.56万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
AdultAgeAgingAmlodipineAnimal ModelAnimalsBlood PressureBlood VesselsC-reactive proteinCardiac MyocytesCardiovascular DiseasesCardiovascular systemChronic Kidney FailureClinicalClinical ResearchDahl Hypertensive RatsDataDevicesDiabetes MellitusDisease modelEnrollmentErythrocytesEthnic OriginExcretory functionExhibitsFemaleFibrosisFutureGenderGlucoseHeart HypertrophyHeightHigh Density Lipoprotein CholesterolHumanHydrochlorothiazideInfusion proceduresLinkLisinoprilMeasuresModelingNa(+)-K(+)-Exchanging ATPaseOxidative StressParticipantPathway interactionsPatientsPhysiologic pulsePhysiologicalPlayRattusRegression AnalysisRenal TissueResistant HypertensionRiskRoleSignal TransductionSmooth Muscle MyocytesSodiumSodium ChlorideSprague-Dawley RatsSteroidsTransferaseTransforming Growth Factor betaVascular Smooth MuscleWomanarterial stiffnessblood pressure regulationcardiovascular risk factordietary saltearly detection biomarkersexperimental studyinhibitor/antagonistmalemarinobufageninmennormotensiveolder patientpotential biomarkerpressureresponsesalt intakesalt sensitive hypertensionsalureticurinaryyoung woman
中文摘要
点击翻译按钮获取中文摘要
英文摘要
There are two pro-fibrotic pathways, Fli1-dependent and TGF-beta-dependent, which are activated by MBG in animal chronic kidney disease models, diabetes and aging, and in the cultured rat vascular smooth muscle cells and cardiac myocytes. The TGF-beta-dependent pathway is activated by heightened MBG in the presence of a high salt intake in cardiovascular and renal tissues from hypertensive Dahl salt-sensitive rats and normotensive Sprague-Dawley rats. We demonstrated in the animal models and in cultured rat cardiac myocytes and vascular smooth muscle cells (i) that Fli1-dependent and TGF-beta-dependent pro-fibrotic pathways exhibit a crosstalk at the level of phosphorylated PKC-delta, (ii) that these pathways are activated either independently, or simultaneously, and (iii) that the activation of the profibrotic signaling is BP independent.
Experiment 1. This clinical study included data of 711 participants (black 51%, men 42%, mean age 24.83.0 years). We measured the carotidfemoral pulse wave velocity (cfPWV), 24-h urinary MBG and sodium excretion. In single, partial and multivariable adjusted regression analyses, we found a persistent positive association between cfPWV and MBG excretion in young women, but not men. Multiple regression models were adjusted for ethnicity, age, waist-to-height ratio, mean arterial BP, high-density lipoprotein cholesterol, C-reactive protein, glutamyl transferase and glucose. In conclusion, already at a young age heightened endogenous MBG levels may contribute to large artery stiffness in women via pressure-independent mechanisms, increasing their risk for future cardiovascular disease.
Experiment 2. Thirty-four patients (18 males and 16 females; 568 years) with RH on a combined (lisinopril/amlodipine/hydrochlorothiazide) therapy and 11 healthy age-matched normotensive subjects (7 males and 4 females; 542 years) were enrolled in this study. Arterial stiffness was measured by Sphygmocor Px device with a calculation of PWV. Activity of Na pump was measured in erythrocytes. We demonstrated that the response of MBG on a moderate sodium chloride administration did not correlate with arterial BP and was associated with PWV in a gender- and age-specific fashion in RH patients vs. normotensive controls.
Conclusion: These findings in human studies corroborate mechanistic data from rat studies whereby stimulation of MBG by a high salt intake or MBG infusion increased vascular fibrosis and cardiac hypertrophy. MBG is a marker of salt-sensitivity and may be a potential biomarker of early cardiovascular risk.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:6969305
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
-
批准号:9553192
-
项目类别:
-
资助金额:$88.87万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:7325141
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
-
批准号:10259332
-
项目类别:
-
资助金额:$256.53万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
SODIUM PUMP INHIBITORS IN BLOOD PRESSURE REGULATION
-
批准号:6097847
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
-
批准号:9553196
-
项目类别:
-
资助金额:$292.07万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
-
批准号:10007363
-
项目类别:
-
资助金额:$291.03万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
-
批准号:10688863
-
项目类别:
-
资助金额:$39.21万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
-
批准号:9351975
-
项目类别:
-
资助金额:$88.45万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Exploring the involvement of Na pump inhibitor marinobufagenin in the interactions between age-associated vascular and neurodegenerative processes in cognitive impairment and Alzheimer's disease
-
批准号:10913151
-
项目类别:
-
资助金额:$219.07万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
-
批准号:10259328
-
项目类别:
-
资助金额:$185.1万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
-
批准号:9351953
-
项目类别:
-
资助金额:$66.27万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
-
批准号:10913121
-
项目类别:
-
资助金额:$151.87万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:6815213
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Sodium Pump Inhibitors In Blood Pressure Regulation
-
批准号:7132287
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
Sodium pump inhibitors in blood pressure regulation and in profibrotic signaling in salt sensitive hypertension and aging
-
批准号:10688841
-
项目类别:
-
资助金额:$151.54万
-
财政年份:--
-
负责人:Olga V Fedorova
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: